IDEXX LABORATORIES INC /DE Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Idexx Laboratories Inc /De quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q2 2024.
  • Idexx Laboratories Inc /De Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $15.7M, a 1.95% increase year-over-year.
  • Idexx Laboratories Inc /De Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $60.5M, a 8.94% increase year-over-year.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2023 was $59.7M, a 20% increase from 2022.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2022 was $49.8M, a 31.8% increase from 2021.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2021 was $37.8M, a 22% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $60.5M $15.7M +$300K +1.95% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $60.2M $14.4M +$500K +3.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $59.7M $15.2M +$1.87M +14% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $57.9M $15.2M +$2.3M +17.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $55.6M $15.4M +$3.1M +25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $52.5M $13.9M +$2.7M +24.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $49.8M $13.4M +$3.62M +37.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $46.2M $12.9M +$3.4M +35.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $42.8M $12.3M +$2.7M +28.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $40.1M $11.2M +$2.3M +25.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $37.8M $9.76M +$1.8M +22.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $36M $9.5M +$1.6M +20.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $34.4M $9.6M +$1.8M +23.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $32.6M $8.9M +$1.6M +21.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $31M $7.95M -$8.73M -52.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $39.7M $7.9M -$1.5M -16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $41.2M $7.8M +$900K +13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $40.3M $7.3M +$1M +15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $39.3M $16.7M +$10.5M +171% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $28.8M $9.4M +$2.9M +44.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $25.9M $6.9M +$400K +6.15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $25.5M $6.3M +$300K +5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $25.2M $6.16M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $6.5M +$400K +6.56% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $6.5M +$500K +8.33% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $6M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q3 2017 $6.1M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.